Andrew Steinsapir

Acting Chief Technology Officer Apertura Gene Therapy

Seminars

Wednesday 25th March 2026
Walking the Walk: CMC & Operational Strategy
11:45 am
  • What can we learn from mature drug developers and biotechs
  • How to manage manufacturing capacity and partners
  • Developing fit for purpose frameworks from virtual companies to pharma
Andrew Steinsapir - Speaker - 9th Gene Therapy Development Summit